Both studies indicate that downregulation of the NDUFA1 gene in the serum of AD patients is likely to lead to impaired oxidative phosphorylation and partial deficiency of mitochondrial function, which is ultimately involved in the disease development of AD. Here, NDUFA1 is linked to Alzheimer disease.